Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.24.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Shares
Common Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Aug. 31, 2023   $ 80 $ 174,689 $ (56,535) $ 118,234
Balance (in shares) at Aug. 31, 2023 432,513 24,078,720      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted shares grants     23   $ 23
Restricted shares grants (in shares)   8,000      
Stock options exercised (in shares)         0
Share-based compensation     58   $ 58
Repurchases of common shares       (198) (198)
Repurchases of common shares (in shares)   (20,000)      
Net income       2,065 2,065
Balance at Nov. 30, 2023   $ 80 174,770 (54,668) 120,182
Balance (in shares) at Nov. 30, 2023 432,513 24,066,720      
Balance at Aug. 31, 2024   $ 80 175,125 (45,503) 129,702
Balance (in shares) at Aug. 31, 2024 432,513 24,063,894      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted shares grants     21   $ 21
Restricted shares grants (in shares)   9,200      
Stock options exercised (in shares)   13,815     13,815
Share-based compensation     35   $ 35
Repurchases of common shares       (108) (108)
Repurchases of common shares (in shares)   (10,000)      
Net income       3,937 3,937
Balance at Nov. 30, 2024   $ 80 $ 175,181 $ (41,674) $ 133,587
Balance (in shares) at Nov. 30, 2024 432,513 24,076,909